Global Continuous Subcutaneous Insulin Infusion Devices Market Growth 2020-2025
According to this study, over the next five years the Continuous Subcutaneous Insulin Infusion Devices market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Continuous Subcutaneous Insulin Infusion Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Subcutaneous Insulin Infusion Devices market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Continuous Subcutaneous Insulin Infusion Devices, covering the supply chain analysis, impact assessment to the Continuous Subcutaneous Insulin Infusion Devices market size growth rate in several scenarios, and the measures to be undertaken by Continuous Subcutaneous Insulin Infusion Devices companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Normal Pump
Patch Pump
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Type I Diabetes
Type II Diabetes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Roche
Tandem Diabetes care
Valeritas
Insulet Corp
SOOIL
Microport
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Continuous Subcutaneous Insulin Infusion Devices consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Continuous Subcutaneous Insulin Infusion Devices market by identifying its various subsegments.
Focuses on the key global Continuous Subcutaneous Insulin Infusion Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Continuous Subcutaneous Insulin Infusion Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Continuous Subcutaneous Insulin Infusion Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption 2015-2025
2.1.2 Continuous Subcutaneous Insulin Infusion Devices Consumption CAGR by Region
2.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
2.2.1 Normal Pump
2.2.2 Patch Pump
2.3 Continuous Subcutaneous Insulin Infusion Devices Consumption by Type
2.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
2.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Type (2015-2020)
2.3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2015-2020)
2.4 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
2.4.1 Type I Diabetes
2.4.2 Type II Diabetes
2.5 Continuous Subcutaneous Insulin Infusion Devices Consumption by Application
2.5.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
2.5.2 Global Continuous Subcutaneous Insulin Infusion Devices Value and Market Share by Type (2015-2020)
2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2015-2020)
3 Global Continuous Subcutaneous Insulin Infusion Devices by Company
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company
3.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Company (2018-2020)
3.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2018-2020)
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company
3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2018-2020)
3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2018-2020)
3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company
3.4 Global Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Continuous Subcutaneous Insulin Infusion Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Continuous Subcutaneous Insulin Infusion Devices by Regions
4.1 Continuous Subcutaneous Insulin Infusion Devices by Regions
4.2 Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Growth
4.3 APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Growth
4.4 Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Growth
4.5 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Growth
5 Americas
5.1 Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries
5.1.1 Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020)
5.1.2 Americas Continuous Subcutaneous Insulin Infusion Devices Value by Countries (2015-2020)
5.2 Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Type
5.3 Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Regions
6.1.1 APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Regions (2015-2020)
6.1.2 APAC Continuous Subcutaneous Insulin Infusion Devices Value by Regions (2015-2020)
6.2 APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Type
6.3 APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Continuous Subcutaneous Insulin Infusion Devices by Countries
7.1.1 Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020)
7.1.2 Europe Continuous Subcutaneous Insulin Infusion Devices Value by Countries (2015-2020)
7.2 Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Type
7.3 Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices by Countries
8.1.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Value by Countries (2015-2020)
8.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption by Type
8.3 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Continuous Subcutaneous Insulin Infusion Devices Distributors
10.3 Continuous Subcutaneous Insulin Infusion Devices Customer
11 Global Continuous Subcutaneous Insulin Infusion Devices Market Forecast
11.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption Forecast (2021-2025)
11.2 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Regions
11.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Regions (2021-2025)
11.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Type
11.8 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Application
12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Information
12.1.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Roche
12.2.1 Company Information
12.2.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Roche Latest Developments
12.3 Tandem Diabetes care
12.3.1 Company Information
12.3.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.3.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Tandem Diabetes care Latest Developments
12.4 Valeritas
12.4.1 Company Information
12.4.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.4.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Valeritas Latest Developments
12.5 Insulet Corp
12.5.1 Company Information
12.5.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.5.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Insulet Corp Latest Developments
12.6 SOOIL
12.6.1 Company Information
12.6.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 SOOIL Latest Developments
12.7 Microport
12.7.1 Company Information
12.7.2 Continuous Subcutaneous Insulin Infusion Devices Product Offered
12.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Microport Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Continuous Subcutaneous Insulin Infusion Devices Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Normal Pump
Table 5. Major Players of Patch Pump
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
Table 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2015-2020) ($ million)
Table 9. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
Table 13. Global Continuous Subcutaneous Insulin Infusion Devices Value by Application (2015-2020)
Table 14. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Application (2015-2020)
Table 15. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2015-2020)
Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Company (2017-2019) (K Units)
Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2017-2019)
Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2017-2019)
Table 20. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company (2017-2019)
Table 21. Global Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Continuous Subcutaneous Insulin Infusion Devices Products Offered
Table 23. Continuous Subcutaneous Insulin Infusion Devices Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Continuous Subcutaneous Insulin Infusion Devices Consumption by Regions 2015-2020 (K Units)
Table 25. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Regions 2015-2020
Table 26. Global Continuous Subcutaneous Insulin Infusion Devices Value by Regions 2015-2020 ($ Millions)
Table 27. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Regions 2015-2020
Table 28. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries (2015-2020)
Table 30. Americas Continuous Subcutaneous Insulin Infusion Devices Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Countries (2015-2020)
Table 32. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Type (2015-2020) (K Units)
Table 33. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
Table 34. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption by Application (2015-2020) (K Units)
Table 35. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
Table 36. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries (2015-2020)
Table 38. APAC Continuous Subcutaneous Insulin Infusion Devices Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Regions (2015-2020)
Table 40. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Type (2015-2020) (K Units)
Table 41. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
Table 42. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption by Application (2015-2020) (K Units)
Table 43. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
Table 44. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries (2015-2020)
Table 46. Europe Continuous Subcutaneous Insulin Infusion Devices Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Countries (2015-2020)
Table 48. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Type (2015-2020) (K Units)
Table 49. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
Table 50. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Application (2015-2020) (K Units)
Table 51. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
Table 60. Continuous Subcutaneous Insulin Infusion Devices Distributors List
Table 61. Continuous Subcutaneous Insulin Infusion Devices Customer List
Table 62. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Forecast by Regions
Table 64. Global Continuous Subcutaneous Insulin Infusion Devices Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share Forecast by Regions
Table 66. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Continuous Subcutaneous Insulin Infusion Devices Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share Forecast by Type (2021-2025)
Table 70. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Continuous Subcutaneous Insulin Infusion Devices Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share Forecast by Application (2021-2025)
Table 74. Medtronic Product Offered
Table 75. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Medtronic Main Business
Table 77. Medtronic Latest Developments
Table 78. Medtronic Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Product Offered
Table 80. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Roche Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Tandem Diabetes care Product Offered
Table 85. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Tandem Diabetes care Main Business
Table 87. Tandem Diabetes care Latest Developments
Table 88. Tandem Diabetes care Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Valeritas Product Offered
Table 90. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Valeritas Main Business
Table 92. Valeritas Latest Developments
Table 93. Valeritas Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Insulet Corp Product Offered
Table 95. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Insulet Corp Main Business
Table 97. Insulet Corp Latest Developments
Table 98. Insulet Corp Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. SOOIL Product Offered
Table 100. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. SOOIL Main Business
Table 102. SOOIL Latest Developments
Table 103. SOOIL Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Microport Product Offered
Table 105. Microport Basic Information, Company Total Revenue (in $ million), Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. Microport Main Business
Table 107. Microport Latest Developments
Table 108. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Continuous Subcutaneous Insulin Infusion Devices
Figure 2. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Continuous Subcutaneous Insulin Infusion Devices Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Normal Pump
Figure 7. Product Picture of Patch Pump
Figure 8. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type (2015-2020)
Figure 9. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Type (2015-2020)
Figure 10. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type I Diabetes
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type I Diabetes (2015-2020) (K Units)
Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type I Diabetes (2015-2020) ($ Millions)
Figure 13. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type II Diabetes
Figure 14. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type II Diabetes (2015-2020) (K Units)
Figure 15. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type II Diabetes (2015-2020) ($ Millions)
Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Application (2015-2020)
Figure 18. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company in 2017
Figure 19. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company in 2019
Figure 20. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company in 2017
Figure 21. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company in 2019
Figure 22. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company in 2019
Figure 23. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Regions 2015-2020
Figure 24. Global Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Regions 2015-2020
Figure 25. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption 2015-2020 (K Units)
Figure 26. Americas Continuous Subcutaneous Insulin Infusion Devices Value 2015-2020 ($ Millions)
Figure 27. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption 2015-2020 (K Units)
Figure 28. APAC Continuous Subcutaneous Insulin Infusion Devices Value 2015-2020 ($ Millions)
Figure 29. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption 2015-2020 (K Units)
Figure 30. Europe Continuous Subcutaneous Insulin Infusion Devices Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Value 2015-2020 ($ Millions)
Figure 33. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries in 2019
Figure 34. Americas Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Countries in 2019
Figure 35. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type in 2019
Figure 36. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application in 2019
Figure 37. United States Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 38. United States Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries in 2019
Figure 44. APAC Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Regions in 2019
Figure 45. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type in 2019
Figure 46. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application in 2019
Figure 47. China Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 48. China Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 55. India Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 56. India Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries in 2019
Figure 60. Europe Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Countries in 2019
Figure 61. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type in 2019
Figure 62. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application in 2019
Figure 63. Germany Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 65. France Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 66. France Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 67. UK Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 68. UK Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application in 2019
Figure 77. Egypt Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Continuous Subcutaneous Insulin Infusion Devices Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Continuous Subcutaneous Insulin Infusion Devices Value Growth 2015-2020 ($ Millions)
Figure 87. Global Continuous Subcutaneous Insulin Infusion Devices Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Continuous Subcutaneous Insulin Infusion Devices Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 90. Americas Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 91. APAC Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 92. APAC Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 93. Europe Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 94. Europe Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 97. United States Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 98. United States Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 99. Canada Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 100. Canada Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 101. Mexico Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 102. Mexico Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 103. Brazil Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 104. Brazil Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 105. China Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 106. China Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 107. Japan Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 108. Japan Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 109. Korea Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 110. Korea Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 113. India Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 114. India Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 115. Australia Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 116. Australia Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 117. Germany Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 118. Germany Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 119. France Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 120. France Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 121. UK Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 122. UK Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 123. Italy Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 124. Italy Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 125. Russia Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 126. Russia Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 127. Spain Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 128. Spain Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 129. Egypt Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 130. Egypt Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 131. South Africa Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 132. South Africa Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 133. Israel Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 134. Israel Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 135. Turkey Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 136. Turkey Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Continuous Subcutaneous Insulin Infusion Devices Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Continuous Subcutaneous Insulin Infusion Devices Value 2021-2025 ($ Millions)
Figure 139. Medtronic Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
Figure 140. Roche Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
Figure 141. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
Figure 142. Valeritas Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
Figure 143. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
Figure 144. SOOIL Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
Figure 145. Microport Continuous Subcutaneous Insulin Infusion Devices Market Share (2018-2020)
